Weight-Loss Drugs Cut Cardiovascular Risk
In the SELECT trial, semaglutide lowered the risk of heart attack and stroke by about 20% in people with obesity and no diabetes.
Cellular Reprogramming: Scientists Try to Reverse Aging
Partial cellular reprogramming rejuvenates cells in experiments and restored vision in old mice; in 2026 it reached its first human trial.
Rapamycin in Healthy Adults: First PEARL Trial Results
One of the first randomized trials of rapamycin in healthy adults: the drug was tolerated reasonably well over about a year, but it showed no breakthrough.
Taurine Deficiency May Accelerate Aging, Study Finds
In mice and monkeys, restoring taurine improved health and extended lifespan, but in humans the link to aging is still only observational.